Search Results
Search for other papers by J. F. Tait in
Google Scholar
PubMed
Search for other papers by S. A. S. Tait in
Google Scholar
PubMed
ABSTRACT
Earlier views indicated that globulin (corticosteroid-binding globulin (CBG) or sex hormone-binding globulin (SBG)) but not albumin binding in plasma, protects steroids from splanchnic metabolism in man. Also, the splanchnic extraction (HE) of a steroid seemed to be highly dependent on the rate of disassociation of the steroid–protein complex. However, the faster rate of disassociation (τ½ = 0·9 s) of cortisol–CBG, as determined by later accurate fluorescence methods, intuitively meant that this complex must disassociate completely in a single 9 s passage through the liver. The low HE of total cortisol was then a puzzling anomaly.
Using a differential equation solver (TUTSIM) and a model with unbound, albumin- and globulin-bound pools of steroid (with metabolism of unbound and also possibly albumin-bound steroid), the mechanism of splanchnic metabolism has been studied. The 'complex', probably most realistic, model includes 13 steroids, which can simultaneously bind to plasma albumin, CBG and SBG. The steroid concentration and numbers of occupied binding sites of the globulins decrease during the time of metabolism. The experimental data used are the in-vitro binding characteristics of the steroid–protein complexes, including the equilibrium constants and rates of disassociation and the in-vivo HE of nine steroids, usually measured by direct analysis of hepatic venous blood. However, the HE of cortisol had to be calculated from the metabolic clearance rate/splanchnic blood flow, giving a maximum value of 12%.
The fractional metabolic rate of unbound steroid is generally represented by e. A certain value of e (RE) is required to give a remaining steroid concentration after 9 s of metabolism, which is made equal to (1–HE) in the model to simulate splanchnic extraction. If the fractional rate of metabolism of albumin-bound steroid is h (f = h/e), then RE will depend on the value of f. The maximum RE for cortisol is RE0 = 0·42 and RE1 = 0·16 for f = 0 and 1 respectively. For either value of RE, there will be the appreciable reassociation of cortisol to CBG after disassociation of the cortisol–CBG complex. With such reassociation, the total cortisol remaining after 9 s metabolism is fairly independent of the rate of disassociation of the cortisol–CBG complex. This explains the low total HE of cortisol in spite of the high rate of disassociation of cortisol–CBG. Generally, for all nine steroids studied, HE estimations in vivo in humans indicate that the steroid–globulin disassociation rate will only be markedly rate-limiting for dihydrotestosterone–SBG and, to a lesser extent, testosterone–SBG. These results are examples of the principle that the divergence in hormone concentration with the disassociation rate of the hormone-protein complex after metabolism depends on the value of e.
The RE0 and RE1 values of the nine steroids: aldosterone, progesterone, testosterone, dihydrotestosterone, androstenedione, androstanediol, oestradiol, oestrone and cortisol have also been calculated from all in-vivo HE estimates. If it is assumed that the steroid in the albumin-bound pool is not metabolized (f = 0), then the RE0 values of the nine steroids considered have a large variation (s.d./mean = 115%). There is a correlation between the RE0 values and their albumin-binding index (BIA). However, if f = 1 then the variation of RE is smaller (s.d./mean = 36%) and there is no correlation between RE1 and BIA. The ratio of the RE0 and RE1 values for a particular steroid is nearly equal to (1 + BIA), which is determined solely by the dynamics of the situation. However, the appropriate value of f depends on the mechanisms involved.
With the F1 hypothesis (f = 1), albumin binding does not protect steroids from splanchnic extraction because of metabolism of albumin-bound steroid. With the FO hypothesis (f = 0), this seeming lack of protection of albumin binding is essentially artefactual. Albumin-bound steroid would not be metabolized directly but the fractional rate of metabolism of unbound steroid would be increased with the decreasing polarity of the steroid (i.e. with increasing BIA). With the available data, the choice between the hypotheses can only be on an intuitive basis.
Journal of Endocrinology (1991) 131, 339–357
Search for other papers by Cheryl A Conover in
Google Scholar
PubMed
Search for other papers by Megan A Mason in
Google Scholar
PubMed
Search for other papers by James A Levine in
Google Scholar
PubMed
Search for other papers by Colleen M Novak in
Google Scholar
PubMed
posits that a decrease in overall metabolic rate decreases the production of reactive oxygen species (ROS) during respiration, thereby slowing the aging process (reviewed in Masoro 2005 ). If so, then reduced IGF signaling might result in decreases in
Search for other papers by Sean A Newsom in
Google Scholar
PubMed
Search for other papers by Jennifer C Richards in
Google Scholar
PubMed
Search for other papers by Tyler K Johnson in
Google Scholar
PubMed
Search for other papers by Jessica N Kuzma in
Google Scholar
PubMed
Search for other papers by Mark C Lonac in
Google Scholar
PubMed
Search for other papers by Roger J Paxton in
Google Scholar
PubMed
Search for other papers by Grant M Rynn in
Google Scholar
PubMed
Search for other papers by Wyatt F Voyles in
Google Scholar
PubMed
Search for other papers by Christopher Bell in
Google Scholar
PubMed
overwhelming: during β-AR blockade, both resting metabolic rate (RMR) and the magnitude of increase in EE following energy intake (thermic effect of feeding) are decreased ( Tappy et al . 1986 , Welle et al . 1991 , Bell et al . 2001 , Monroe et al
Search for other papers by Marian Ludgate in
Google Scholar
PubMed
all of the required components and are able to produce thyroid hormone ( Meischl et al . 2008 ). Thyroid hormones are essential to the development and maintenance of, for example, the brain and skeletal system and for regulation of the basal metabolic
Search for other papers by Rosalba Senese in
Google Scholar
PubMed
Search for other papers by Federica Cioffi in
Google Scholar
PubMed
Search for other papers by Pieter de Lange in
Google Scholar
PubMed
Search for other papers by Fernando Goglia in
Google Scholar
PubMed
Search for other papers by Antonia Lanni in
Google Scholar
PubMed
( Kunitake et al . 1989 ) and to increase metabolic rate in obese patients ( Dumas et al . 1982 ). It has been shown to be more potent than T 3 as both a β-adrenergic stimulator of uncoupling protein 1 and inducer of lipoprotein lipase mRNA, D3 activity
Academy of Scientific and Innovative Research, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India
Search for other papers by Sujith Rajan in
Google Scholar
PubMed
Search for other papers by Kripa Shankar in
Google Scholar
PubMed
Search for other papers by Muheeb Beg in
Google Scholar
PubMed
Search for other papers by Salil Varshney in
Google Scholar
PubMed
Search for other papers by Abhishek Gupta in
Google Scholar
PubMed
Academy of Scientific and Innovative Research, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India
Search for other papers by Ankita Srivastava in
Google Scholar
PubMed
Academy of Scientific and Innovative Research, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India
Search for other papers by Durgesh Kumar in
Google Scholar
PubMed
Search for other papers by Raj K Mishra in
Google Scholar
PubMed
Search for other papers by Zakir Hussain in
Google Scholar
PubMed
Search for other papers by Jiaur R Gayen in
Google Scholar
PubMed
Academy of Scientific and Innovative Research, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India
Search for other papers by Anil N Gaikwad in
Google Scholar
PubMed
animal monitoring system (CLAMS) Oxymax/CLAMS (Columbus Instruments, Columbus, OH, USA) were used to quantitate food intake, locomotor activity, oxygen consumption (VO 2 ), carbon dioxide production (VCO 2 ), metabolic rate, and heat production. Mice
Search for other papers by I Sadaf Farooqi in
Google Scholar
PubMed
Search for other papers by Stephen O'Rahilly in
Google Scholar
PubMed
unable to demonstrate a major acute effect of leptin administration on basal metabolic rate as measured by indirect calorimetry, total energy expenditure using chamber calorimetry, or free-living energy expenditure using the doubly-labelled water method
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Cássio M Villicev in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Fatima R S Freitas in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Marcelo S Aoki in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Cássio Taffarel in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Thomas S Scanlan in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Anselmo S Moriscot in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Miriam O Ribeiro in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Antonio C Bianco in
Google Scholar
PubMed
School of Arts, Sciences & Humanities, University of Sao Paulo, Sao Paulo, Brazil
Department of Biosciences, Mackenzie Presbyterian University, Sao Paulo, Brazil
Departments of Pharmaceutical Chemistry & Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA
Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Cecília H A Gouveia in
Google Scholar
PubMed
result in some therapeutically desirable effects, such as increased metabolic rate, lipolysis, cholesterol lowering, improvement of heart contractility and thyroid-stimulating hormone (TSH) suppression, which is beneficial in patients with thyroid cancer
Guangdong Provincial Key Laboratory of Shock and Microcirculation, Guangzhou, China
Search for other papers by Xuan Zhou in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Shock and Microcirculation, Guangzhou, China
Search for other papers by Yanan Zhang in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Shock and Microcirculation, Guangzhou, China
Search for other papers by Youwen Yuan in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Shock and Microcirculation, Guangzhou, China
Search for other papers by Fei Teng in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Shock and Microcirculation, Guangzhou, China
Search for other papers by Jiayang Lin in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Shock and Microcirculation, Guangzhou, China
Search for other papers by Xueru Ye in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Shock and Microcirculation, Guangzhou, China
Search for other papers by Yaojin Pan in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Shock and Microcirculation, Guangzhou, China
Search for other papers by Huijie Zhang in
Google Scholar
PubMed
Introduction Thyroid hormone (TH) performs vital functions in energy expenditure and homeostasis. Under physiological circumstances, TH is essential for sustaining basal metabolic rate (BMR), facilitating adaptive thermogenesis, and modulating
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Noelia Martínez-Sánchez in
Google Scholar
PubMed
Department of Diabetes, Endocrinology and Nutrition, Hospital de Girona ‘Dr Josep Trueta’, Institut D’investigació Biomèdica de Girona (IdIBGi) and University of Girona, Girona, Spain
Search for other papers by José M Moreno-Navarrete in
Google Scholar
PubMed
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Cristina Contreras in
Google Scholar
PubMed
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Eva Rial-Pensado in
Google Scholar
PubMed
Department of Clinical Science, KG Jebsen Center for Diabetes Research, University of Bergen, Bergen, Norway
Search for other papers by Johan Fernø in
Google Scholar
PubMed
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Rubén Nogueiras in
Google Scholar
PubMed
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Carlos Diéguez in
Google Scholar
PubMed
Department of Diabetes, Endocrinology and Nutrition, Hospital de Girona ‘Dr Josep Trueta’, Institut D’investigació Biomèdica de Girona (IdIBGi) and University of Girona, Girona, Spain
Search for other papers by José-Manuel Fernández-Real in
Google Scholar
PubMed
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain
Search for other papers by Miguel López in
Google Scholar
PubMed
the metabolic rate and the patients suffering from this condition undergo body weight loss, despite increased food intake; quite the opposite, hypothyroid patients show lowered metabolic rate and reduced food intake ( Brenta et al . 2007 , Kaptein